Archives
Small-Biopsy Dye Models in Surgical Pathology
2026-09-10
The reference study evaluates whether simple dyes can make 0.2–0.3 cm tissue fragments easier to recognize during routine processing without compromising slide interpretation. It identifies hematoxylin as the most practical marker, while showing that merbromin and Alcian blue can also improve visibility but require greater consideration of toxicity and diagnostic interference.
Enzyme-Induced Hypoxia and Urothelial Inflammation
2026-09-10
The reference study shows that hypoxia duration determines whether rat urothelial cells develop a measurable inflammasome-associated response. Short exposure stabilized HIF-1α and increased nitric oxide activity without increasing caspase-1, whereas longer exposure promoted caspase-1 activity that was attenuated by glutathione or verapamil, supporting a ROS-linked TXNIP/NLRP3 mechanism.
X-Gal A2539: Reliable β-Galactosidase Assays
2026-09-09
This scenario-based guide explains when X-Gal is appropriate for β-galactosidase reporter assays, blue-white colony screening, and molecular cloning—and when it should not replace a direct viability assay. It also details formulation, solubilization, controls, and vendor-selection considerations for X-Gal SKU A2539.
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-09
The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, supports detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. This guide focuses on practical assay setup and QC where no directly matched paper evidence is available; the reagent is for research use only and is not validated for diagnostic, medical, or therapeutic applications.
DNMT Inhibition Restores Innate Antitumor Immunity
2026-09-08
The reference study shows that DNMT inhibition can reverse epigenetic silencing of cGAS–STING while also increasing cytosolic double-stranded RNA signaling through RIG-I/MDA5–MAVS. These complementary innate immune pathways improved interferon-related antitumor activity and provide a mechanistic basis for combining decitabine with cisplatin or immunotherapy-oriented strategies.
TSPAN18–STIM1 Axis in Prostate Cancer Bone Metastasis
2026-09-08
Zhou et al. identify TSPAN18 as a regulator of STIM1 stability, showing that it protects STIM1 from TRIM32-mediated ubiquitination and sustains calcium signaling linked to prostate cancer bone metastasis. The study provides a mechanistic framework for connecting protein turnover, store-operated calcium entry, metastatic behavior, and clinically relevant tumor expression patterns.
Firefly Luciferase mRNA: Workflow & Optimization
2026-09-07
Build more interpretable transfection, gene expression, and delivery studies with an ARCA-capped, modified firefly luciferase transcript. This guide connects routine cell assays to LNP and device-mediated delivery while emphasizing controls, normalization, and troubleshooting.
FAT4, PI3K/AKT, and Ferroptosis in HCC
2026-09-07
A 2026 study identifies FAT4 loss as a driver of hepatocellular carcinoma growth and resistance to ferroptosis-inducing treatments. Its findings connect reduced FAT4 with PI3K/AKT activation, elevated GPX4 and SLC7A11, and impaired responses to RSL3 and sorafenib, suggesting a mechanistic route for restoring treatment sensitivity.
Enzyme-Induced Hypoxia and Urothelial Inflammation
2026-09-05
Hudson and colleagues show that hypoxia duration determines whether rat urothelial cells progress from an adaptive response to caspase-1-associated inflammation. The study identifies a ROS/TXNIP/NLRP3-linked mechanism and positions Verapamil as a useful, but pharmacologically non-specific, probe for testing this pathway in bladder outlet obstruction models.
Solanesol: Practical Hydrophobic Assay Guide
2026-09-04
Solanesol is a defined polyisoprenoid alcohol for controlled hydrophobic-compound handling in biochemical, membrane-related, cell-based, and enzyme workflows. It should be prepared in DMSO rather than water or ethanol, used as a fresh solution when possible, and interpreted within research-only assay boundaries.
TP53, ATM, and MDM2 in Calicheamicin Sensitivity
2026-09-04
This acute leukemia study uses genome-wide CRISPR/Cas9 screening and matched genetic models to define how DNA damage sensing shapes response to calicheamicin, the payload shared by gemtuzumab ozogamicin and inotuzumab ozogamicin. Its key translational result is that TP53 loss confers strong resistance, whereas pharmacologic ATM or MDM2 modulation can enhance calicheamicin activity; PARP inhibition did not produce the same effect in the tested models.
Machine Learning Designs LNPs to Reprogram Microglia
2026-09-03
A 2025 Drug Delivery study combined a 216-formulation lipid nanoparticle library with supervised machine learning to identify carriers that deliver mRNA and modulate hyperactivated microglia. The optimized HA-LNP2 formulation improved IL10 expression and reduced TNF-α-associated inflammatory responses in murine and human iPSC-derived microglia, illustrating how carrier immunological properties can be treated as design variables.
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-09-03
The reference study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer through a B4GALT1–PD-L1 stability axis. RBMS1 depletion reduced PD-L1 abundance, increased cytotoxic T-cell activity, and improved responses to CTLA4 blockade or CAR-T treatment in cellular and animal models.
Chlorpromazine HCl Beyond Dopamine: A Translational Lens
2026-09-02
Chlorpromazine HCl is more than a conventional dopamine receptor antagonist: it is a pharmacological probe for connecting receptor signaling, synaptic physiology, endocytosis, and host-cell defense. This thought-leadership guide outlines how translational researchers can use its established neuropharmacology while responsibly evaluating emerging phenothiazine biology in infection and cell-based research.
Adipose-Neural Signaling in Cardiac Arrhythmias
2026-09-02
The reference preprint identifies a leptin–NPY pathway linking epicardial adipose tissue to sympathetic neurons and arrhythmic cardiomyocyte behavior. Its co-culture and patient-association data provide a mechanistic framework for studying neuro-adipose contributions to arrhythmia while highlighting the need for validation in more complex models.
755 records 9/51 page Previous Next First page 上5页 678910 下5页 Last page